Wednesday, May 4, 2011

Two substances that create early menopause

Perfluorcarbons
Women exposed to high levels of certain household-product chemicals
called perfluorocarbons, or PFCs may go through menopause at a younger age than other women. The chemicals have historically been widely used in products ranging from furniture and carpeting to non-stick pans, plastic food containers and clothing. Their use in the U.S. is set to be phased out by 2015. But PFCs persist in the environment, and the chemicals are found in water, soil, plants, animals and people. The findings, published in the Journal of Clinical Endocrinology & Metabolism, are based on 26,000 West Virginia women whose drinking-water supplies had been contaminated with PFCs from a nearby DuPont plant in 2005 and 2006.

The researchers found that among women older than 42, those with relatively higher levels of PFOS were more likely to have gone through menopause. Of women between the ages of 42 and 51, those in the top 20% for PFOS levels were 40% more likely to have gone through menopause, versus women in the bottom 20%. The odds were even greater among women older than 51. Those with the top PFOS levels were twice as likely to have gone through menopause as those with the lowest levels of the chemical. In addition, blood levels of estrogen generally fell as PFOS levels rose.

Aromatase Inhibitors
AIs are associated with a wide array of symptoms, such as hot flashes and leg cramps, according to a new study presented at the
Ninth Annual American Association for Cancer Research (AACR) International Conference on Frontiers in Cancer Prevention Research. Investigators compared a group of women receiving AIs to a control group to a non-tamoxifen-taking group. They found that women taking AIs, in terms of new onset of symptoms during the study period, were:
  • 5 times more likely to report having hot flashes, breast sensitivity, and chest pain than healthy women
  • 4 times more likely to report night sweats, cold sweats, and hair loss
  • 3 times more likely to report leg cramps, weight gain, sleep disturbance, tendency to take naps, and forgetfulness.
The researchers called this side effect "menopause plus" and go on to say that research into the adverse effects of AIs is "about to explode," meaning that researchers have now turned their attention to this troubling aspect of the highly effective treatments.

2 comments:

Frannye said...

What are aromatase inhibitors?

nutrocon@aol.com said...

Aromatase inhibitors stop the production of estrogen in women. They are a class of drugs used in the treatment of breast cancer and ovarian cancer in women.

Post a Comment